157. Sturge-Weber syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 10 / Drugs : 13 - (DrugBank : 4) / Drug target genes : 5 - Drug target pathways : 63
Sturge-Weber syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 157 | Sturge-Weber syndrome | - |
| 158 | Tuberous sclerosis | 5.000 |
| 6 | Parkinson disease | 5.000 |
| 46 | Malignant rheumatoid arthritis | 5.000 |
| 96 | Crohn disease | 5.000 |
| 193 | Prader-Willi syndrome | 3.263 |
| 2 | Amyotrophic lateral sclerosis | 3.219 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 3.212 |
| 278 | Huge lymphatic malformation with cervicofacial lesion | 2.520 |
| 36 | Epidermolysis bullosa | 1.873 |
| 17 | Multiple system atrophy | 1.859 |
| 226 | Interstitial cystitis with Hunners ulcer | 1.856 |
| 85 | Idiopathic interstitial pneumonia | 1.836 |
| 86 | Pulmonary arterial hypertension | 1.836 |
| 57 | Idiopathic dilated cardiomyopathy | 1.067 |
| 169 | Menkes disease | 1.067 |
| 170 | Occipital horn syndrome | 1.067 |
| 167 | Marfan syndrome | 1.040 |
| 192 | Cockayne syndrome | 1.000 |
| 277 | Lymphangiomatosis | 1.000 |
| 281 | Klippel-Trenaunay-Weber syndrome | 1.000 |
| 111 | Congenital myopathy | 1.000 |
| 137 | Focal cortical dysplasia | 1.000 |